S2Medical AB (publ) (S2M.ST)
SEK 0.01
(4.55%)
SEK 0.01
(4.55%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - SEK | 0.0% |
| 2022 | - SEK | -100.0% |
| 2021 | 207.69 Thousand SEK | -75.0% |
| 2020 | 830.76 Thousand SEK | -44.95% |
| 2019 | 1.5 Million SEK | -32.55% |
| 2018 | 2.23 Million SEK | 1255.89% |
| 2017 | 165 Thousand SEK | 0.0% |
| 2016 | - SEK | -100.0% |
| 2015 | 3 Million SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - SEK | 0.0% |
| 2024 Q2 | - SEK | 0.0% |
| 2023 Q3 | - SEK | 0.0% |
| 2023 Q1 | - SEK | 0.0% |
| 2023 Q2 | - SEK | 0.0% |
| 2023 FY | - SEK | 0.0% |
| 2023 Q4 | - SEK | 0.0% |
| 2022 Q3 | - SEK | 0.0% |
| 2022 Q2 | - SEK | -100.0% |
| 2022 FY | - SEK | -100.0% |
| 2022 Q4 | - SEK | 0.0% |
| 2022 Q1 | 52 Thousand SEK | -74.96% |
| 2021 Q3 | 364 Thousand SEK | -29.87% |
| 2021 FY | 207.69 Thousand SEK | -75.0% |
| 2021 Q4 | 207.69 Thousand SEK | -42.94% |
| 2021 Q2 | 519 Thousand SEK | -23.11% |
| 2021 Q1 | 675 Thousand SEK | -18.75% |
| 2020 FY | 830.76 Thousand SEK | -44.95% |
| 2020 Q1 | 1.32 Million SEK | -12.06% |
| 2020 Q2 | 1.15 Million SEK | -12.81% |
| 2020 Q3 | 994 Thousand SEK | -14.09% |
| 2020 Q4 | 830.76 Thousand SEK | -16.42% |
| 2019 Q4 | 1.5 Million SEK | -10.87% |
| 2019 FY | 1.5 Million SEK | -32.55% |
| 2019 Q3 | 1.69 Million SEK | -9.75% |
| 2019 Q2 | 1.87 Million SEK | -8.84% |
| 2019 Q1 | 2.05 Million SEK | -8.01% |
| 2018 Q1 | - SEK | -100.0% |
| 2018 Q4 | 2.23 Million SEK | 0.0% |
| 2018 FY | 2.23 Million SEK | 1255.89% |
| 2018 Q2 | 227 Thousand SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 FY | 165 Thousand SEK | 0.0% |
| 2017 Q4 | 165 Thousand SEK | -94.25% |
| 2017 Q3 | 2.86 Million SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 FY | - SEK | -100.0% |
| 2015 FY | 3 Million SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.28 Billion SEK | 100.0% |
| Biotage AB (publ) | 150 Million SEK | 100.0% |
| Bonesupport Holding AB (publ) | 17.48 Million SEK | 100.0% |
| Doxa AB (publ) | 9.7 Million SEK | 100.0% |
| Elekta AB (publ) | 7.24 Billion SEK | 100.0% |
| iZafe Group AB (publ) | 3.17 Million SEK | 100.0% |
| Ortivus AB (publ) | 5.48 Million SEK | 100.0% |
| Ortivus AB (publ) | 5.48 Million SEK | 100.0% |
| Q-linea AB (publ) | 20.56 Million SEK | 100.0% |
| Synsam AB (publ) | 3.25 Billion SEK | 100.0% |